BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6774549)

  • 1. Treatment of multiple myeloma.
    Alexanian R
    Acta Haematol; 1980; 63(5):237-40. PubMed ID: 6774549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 3. Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: a pilot study.
    Alberts DS; Salmon SE
    Cancer Chemother Rep; 1975; 59(2 Pt 1):345-50. PubMed ID: 1097093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance to alkylating agents in multiple myeloma.
    Bladé J; Feliú E; Rozman C; Estapé J; Millá A; Montserrat E
    Cancer; 1983 Sep; 52(5):786-9. PubMed ID: 6871821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
    Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
    Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).
    Kyle RA; Seligman BR; Wallace HJ; Silver RT; Glidewell O; Holland JF
    Cancer Chemother Rep; 1975; 59(3):557-62. PubMed ID: 1203882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further progress in the treatment of multiple myeloma?
    Malik PS; Kumar L
    Natl Med J India; 2009; 22(1):25-7. PubMed ID: 19761157
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of multiple myeloma and its complications].
    Avvisati G; Pulsoni A; Petrucci MT; Tribalto M
    Recenti Prog Med; 1990 Oct; 81(10):642-50. PubMed ID: 2291008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
    Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
    Anderson KC; Palumbo A;
    Oncology (Williston Park); 2005 Apr; 19(4):447-50. PubMed ID: 15934516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleural effusion as a first sign of Ig D lambda multiple myeloma].
    Maachi M; Fellahi S; Diop ME; Francois T; Capeau J; Bastard JP
    Ann Med Interne (Paris); 2003 Feb; 154(1):70-2. PubMed ID: 12746663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four months with a dull pain in the back.
    Cardamone JM
    Mod Med Asia; 1977 Mar; 13(3):12-3. PubMed ID: 145539
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy.
    Donofrio PD; Albers JW; Greenberg HS; Mitchell BS
    Muscle Nerve; 1984 Feb; 7(2):137-41. PubMed ID: 6325905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress report on vindesine treatment of melphalan-resistant multiple myeloma.
    van Dobbenburgh OA; Houwen B; Halie MR; Marrink J; Ockhuizen T; Nieweg HO
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):861-2. PubMed ID: 6683653
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma management.
    Doll DC; Weiss RB
    W V Med J; 1977 Jul; 73(7):151-5. PubMed ID: 267379
    [No Abstract]   [Full Text] [Related]  

  • 19. [Smoldering myeloma].
    Dolgos J; Patakfalvi A
    Orv Hetil; 1993 Sep; 134(39):2155-7. PubMed ID: 8414460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Hitz F
    Praxis (Bern 1994); 2016; 105(21):1255-1260. PubMed ID: 28573955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.